GlassScriptPhysician profile
Thomas W Shin
NPI 1326241266
$18,113.68
in general payments reported to CMS, 2019-2025
12 companies · $3,060 in 2025
The $3,060 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.15 · 2021: $5,659 · 2022: $6,930 · 2023: $767 · 2024: $1,684 · 2025: $3,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,520 · Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,519.85 |
| Food and Beverage | $1,990.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,791.85 | 2020-2024 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $2,528.06 | 2023-2025 | Phasix Mesh |
| Davol INC. | $1,929.35 | 2022-2025 | Phasix Mesh, Bard 3dmax Mesh |
| W. L. Gore & Associates, INC. | $952.36 | 2021 | |
| Enterra Medical, INC. | $594.96 | 2025 | |
| Olympus America INC. | $148.07 | 2024 | Endocapsule Recorder, Visiglide, Hanarostent Esophagus Tts(Ccc) |
| Medtronic, INC. | $61.08 | 2023-2024 | Concertotm, Eea |
| Ascensia Diabetes Care US INC. | $33.69 | 2025 | |
| Convatec INC. | $22.20 | 2024 | |
| Merit Medical Systems INC | $17.69 | 2024 | Savi Scout |
| Tela Bio, INC. | $17.65 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lsi Solutions INC | $16.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.